Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a Scleroderma Patient-centered Intervention Network Cohort Study

Affiliations

• ¹ Lady Davis Institute for Medical Research, Jewish General Hospital, Québec, Canada.
• ² Department of Psychiatry, McGill University, Montréal, Québec, Canada.
• ³ Clinical Psychology, Behavioural Science Institute, Radboud University, Nijmegen, the Netherlands.
• ⁴ Department of Medicine, McGill UniversityMontréal, Québec, Canada.
• ⁵ Department of Epidemiology, Biostatistics, and Occupational HealthMcGill University, Montréal, Québec, Canada.
• ⁶ Department of Educational and Counselling PsychologyMcGill University, Montréal, Québec, Canada.
• ⁷ Department of PsychologyMcGill University, Montréal, Québec, Canada.
• ⁸ School of Nursing, McGill University, Montréal, Québec, Canada.
• ⁹ University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, Michigan, USA.
• ¹⁰ Division of Rheumatology, Geffen School of Medicine, University of California, Los Angeles.
• ¹¹ Scleroderma Foundation, Danvers, MA, USA.
• ¹² Department of Rheumatology, Radboud University Medical Center, Nijmegen, The Netherlands.
• ¹³ Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
• ¹⁴ Department of Psychology, San Diego State University, San Diego, CA.
• ¹⁵ San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University and the University of California, San Diego, CA.
• ¹⁶ Department of Internal Medicine, Division of Rheumatology, McGovern Medical School, University of Texas, Houston, TX, USA.
• ¹⁷ Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France.
• ¹⁸ Service de Médecine Interne, Hôpital Cochin, Paris, France.
• ¹⁹ Beryl & Richard Ivey Rheumatology Day Programs, St Joseph's Health Care, Ontario, Canada.
• ²⁰ Lawson Health Research Institute, London, Ontario, Canada.
• ²¹ Service de Médecine Physique et Réadaptation, Hôpital Cochin.
• ²² IFR Handicap, INSERM, Paris, France.
• ²³ Scleroderma Society of Ontario, Hamilton.
• ²⁴ Scleroderma Society of Canada, Ottawa, ON, Canada.
• ²⁵ Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ²⁶ McGill University Health Center, Montréal, Québec, Canada.